GCR 100 - 18th Edition

Venable

17 January 2018

United States: Washington, DC

Venable antitrust chair Lisa Jose Fales works out of Washington, DC and the firm continues to act for several drugmakers after its big win in the Nexium pay-for-delay trial for defendant Ranbaxy – now Sun Pharmaceuticals. In the latest victory for Sun, an appellate court in September 2016 reversed the trial judge’s decision to certify a class of fewer than two dozen direct purchasers of anti-narcolepsy drug Provigil. The team says clients are bullish to go to trial using Venable, and they boast having more referrals and a stronger profile than two years ago. The firm also defends Impax Laboratories against allegations of an anticompetitive conspiracy to delay entry of a generic version of pain medication Opana ER and acne drug Solodyn. Beyond the pharmaceutical industry, Venable advises Perdue Farms in its defence against class action complaints brought by broiler chicken buyers who accuse poultry producers of conspiring to fix prices by restricting output. Venable assisted the plaintiff class in the O’Bannon antitrust suit against the National Collegiate Athletic Association over the use of college players’ likenesses without payment.

Previous Chapter:Stikeman Elliott

Next Chapter:Von Wobeser y Sierra